Growth Hormone

  • Bengt-Åke Bengtsson

Part of the Endocrine Updates book series (ENDO, volume 4)

Table of contents

  1. Front Matter
    Pages i-xiii
  2. Growth hormone secretion and mechanisms of action

    1. Front Matter
      Pages 1-1
    2. John-Olov Jansson, Suzanne L. Dickson
      Pages 3-15
    3. Gerhard Baumann
      Pages 37-57
    4. Jeff M. P. Holly, Janet K. Fernihough
      Pages 77-96
    5. E. R. Christ, P. V. Carroll, P. H. Sönksen
      Pages 97-108
    6. David M. Hoffman, Ken K. Y. Ho
      Pages 109-126
    7. Jens Sandahl Christiansen, Troels Krarup Hansen, Steen Nielsen, Jens Otto Lunde Jörgensen
      Pages 127-132
  3. Growth hormone replacement therapy in adult GH deficient patients

    1. Front Matter
      Pages 133-133
    2. Thord Rosén
      Pages 135-148
    3. Gudmundur Johannsson
      Pages 149-162
    4. D. L. Russell-Jones, A. M. Umpleby
      Pages 163-172
    5. Kerstin Landin-Wilhelmsen
      Pages 173-188
    6. Christoph J. Auernhammer, Martin Bidlingmaier, Christian J. Strasburger
      Pages 189-225
    7. Jens Otto Lunde Jørgensen, Rolf Dall, Nina Vahl, Helene Nørrelund, Jens Sandahl Christiansen
      Pages 227-236
    8. Jörgen Isgaard
      Pages 253-260
    9. S J Howell, A Rahim, S M Shalet
      Pages 281-290
    10. John P. Monson
      Pages 291-305
  4. New frontiers in adult GH therapy

    1. Front Matter
      Pages 307-307
    2. Antonio Cittadini, Serafino Fazio, Luigi Sacca
      Pages 309-323
    3. Douglas Wilmore
      Pages 325-333
    4. Cyril Y. Bowers
      Pages 335-351
  5. Back Matter
    Pages 353-359

About this book


Growth Hormone is a fitting addition to the Endocrine Updates Series. The aim of these publications is to provide the clinician with cutting-edge, yet succinct, access to the latest advances in endocrinology. Current interest in this rapidly evolving area of endocrinology makes this a timely and important update. Growth Hormone joins Dr. Fagin's Thyroid Cancer in continuing the standard of excellence as the fourth volume in this series of topical updates.
Shlomo Melmed, MD, Series Editor, Endocrine Updates
Ten years ago, many endocrinologists were still skeptical that growth hormone (GH) played an active role in adult metabolism. This is, perhaps, surprising given that GH deficiency (GHD) in adulthood had been `recognized' as long ago as the 1960s.
During the last ten years studies have shown that GHD in adulthood is a far-reaching syndrome associated with abnormal body composition, reduced bone mineral density with an increased fracture rate, increased cardiovascular morbidity and impaired cardiac function, as well as reduced exercise performance and decreased psychological well-being. Importantly, it is also clear, from placebo-controlled trials, that GH replacement therapy can normalize body composition, increase bone mineral content and improve the cardiovascular risk factor profile. GH replacement therapy also improves cardiac performance and exercise capacity, increases muscle strength and improves well-being and quality of life.
The aim of Growth Hormone is to provide a critical update of current knowledge about adult GHD and the future role of GH/IGF-1 in adult medicine. For this purpose, contributions from a number of research groups have been invited. It is my hope that the book may not only serve as an introduction to the field, but also stimulate further research within this exciting area.


G proteins Insulin cardiac function cardiovascular growth factor insulin-like signal transduction

Editors and affiliations

  • Bengt-Åke Bengtsson
    • 1
  1. 1.Sahlgrenska University HospitalGöteborgSweden

Bibliographic information

  • DOI
  • Copyright Information Kluwer Academic Publishers 1999
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4613-7351-3
  • Online ISBN 978-1-4615-5163-8
  • Series Print ISSN 1566-0729
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Internal Medicine & Dermatology